炎性乳腺癌15例临床分析  

Analysis of 15 cases of patient with inflammatory breast cancer

作　　者：毛杰[1] 海健[1] 刘少华[1] 唐利立[1] 申正堂[1] 

机构地区：[1]中南大学湘雅医院乳腺科,湖南长沙410008

出　　处：《中国医学工程》2005年第3期312-313,318,共3页China Medical Engineering

摘　　要：目的该探讨炎性乳腺癌的临床特征、治疗和预后.方法对1994年10月～2005年1月收治的15例炎性乳腺癌患者的临床资料进行回顾性分析.结果炎性乳腺癌的主要症状为乳房皮肤的局部或弥漫红肿,不发热.15例患者中位年龄45岁,Ⅲb期9例,Ⅳ期6例,均首选新辅助化疗.中位生存期18个月,1a生存率78.60%,3 a生存率23.80%.分期早者较分期晚者预后好.结论炎性乳腺癌应采用以化疗为主的综合治疗.[Objective] The purpose of this study wasto investigate the clinical characters, treatment, and prognosis of inflammatory breast cancer. [Method] Fifteen patients with inflammatory breast cancer who were diagnosed and treated from October 1994 to Janury 2005 in our hospital were analyzed retrospectively. [Result] All IBC patients presented clinically with an erythematous or swollen and tender breast, no fever. The median age of 15 patients was 45 years old. Nine patients were stage Ⅲb and six in stage Ⅳ. The initial therapy were neoadjuvant chemtherapy for all patients. Median suevival wes 18 months. The 1 year and 3 year survival rates were 78.60% and 23.80%. Earlier stage showed more favorable prognosis. [Conclusion] Combination therapy with neoadjuvant chemotherapy is an effective treatment for IBC.

关 键 词：炎性乳腺癌 化疗 IBC 炎症表现 

分 类 号：R737.9[医药卫生—肿瘤]